Display Settings:

Format
Items per page

Send to:

Choose Destination

Results: 1 to 20 of 46

1.

Leptin

a substance produced by fat cells and involved in the regulation of appetite [from CHV]

MedGen UID:
81112
Concept ID:
C0299583
Pharmacologic Substance
2.

Thyrotropin

A hormone produced by the pituitary gland. TSH stimulates the release of thyroid hormone from thyroglobulin. It also stimulates the growth of thyroid follicular cells. An abnormal TSH level may mean that the thyroid hormonal regulation system is out of control, usually as a result of a benign condition (hyperthyroidism or hypothyroidism). [from NCI]

MedGen UID:
21551
Concept ID:
C0040160
Pharmacologic Substance
3.

Thyrotropin-Releasing Hormone

Expressed (highest) in the medial hypothalamic paraventricular nuclei and median eminence by human TRH Gene, 242-aa 27-kDa (precursor) (prepro-)Thyrotropin-Releasing Hormone is a major regulator of TSH biosynthesis and release in the anterior pituitary gland and neurotransmitter/neuromodulator in the central and peripheral nervous systems. (NCI) [from NCI]

MedGen UID:
21175
Concept ID:
C0040162
Pharmacologic Substance
4.

Somatotropin preparation

A protein made by the pituitary gland that helps control body growth and the use of glucose and fat in the body. [from NCI]

MedGen UID:
20836
Concept ID:
C0037663
Pharmacologic Substance
5.

Amenorrhea

Absence of menstruation. [from MeSH]

MedGen UID:
8016
Concept ID:
C0002453
Disease or Syndrome
6.

Lipodystrophy

A congenital or acquired disorder characterized by abnormal loss or redistribution of the adipose tissue in the body. [from NCI]

MedGen UID:
6111
Concept ID:
C0023787
Disease or Syndrome
7.

Insulin

Insulin (51 aa, ~6 kDa) is encoded by the human INS gene. This protein is involved in the direct regulation of glucose metabolism. [from NCI]

MedGen UID:
5827
Concept ID:
C0021641
Pharmacologic Substance
8.

Anorexia nervosa

A disorder most often seen in adolescent females characterized by a refusal to maintain a minimally normal body weight, an intense fear of gaining weight, a disturbance in body image, and, in postmenarcheal females, the development of amenorrhea. [from NCI]

MedGen UID:
316
Concept ID:
C0003125
Mental or Behavioral Dysfunction
9.

Anorexia

A disorder characterized by a loss of appetite. [from NCI]

MedGen UID:
315
Concept ID:
C0003123
Sign or Symptom
10.

thyrotropin-releasing hormone

MedGen UID:
832568
Concept ID:
CN198208
Disease or Syndrome
11.

Congenital leptin deficiency

MedGen UID:
824600
Concept ID:
C3838754
Disease or Syndrome
12.

Acquired lipodystrophy

MedGen UID:
798705
Concept ID:
C0877192
Disease or Syndrome
13.

LEPTIN DEFICIENCY

MedGen UID:
767138
Concept ID:
C3554224
Disease or Syndrome
14.

Anorexia

MedGen UID:
743955
Concept ID:
C1971624
Finding
15.

Energy

MedGen UID:
603300
Concept ID:
C0424589
Finding
16.

Hypothalamic amenorrhea

MedGen UID:
574679
Concept ID:
C0341862
Disease or Syndrome
17.

Lipodystrophy

Degenerative changes of the fat tissue. [from HPO]

MedGen UID:
506291
Concept ID:
CN008015
Finding
18.

Amenorrhea

Absence of menses for an interval of time equivalent to a total of =3 previous cycles or 6 months. [from HPO]

MedGen UID:
504362
Concept ID:
CN000137
Finding
19.

Obesity, severe, due to leptin deficiency

Congenital leptin deficiency is a condition that causes severe obesity beginning in the first few months of life. Affected individuals are of normal weight at birth, but they are constantly hungry and quickly gain weight. Without treatment, the extreme hunger continues and leads to chronic excessive eating (hyperphagia) and obesity. Beginning in early childhood, affected individuals develop abnormal eating behaviors such as fighting with other children over food, hoarding food, and eating in secret. People with congenital leptin deficiency also have hypogonadotropic hypogonadism, which is a condition caused by reduced production of hormones that direct sexual development. Without treatment, affected individuals experience delayed puberty or do not go through puberty, and may be unable to conceive children (infertile). [from GHR]

MedGen UID:
433678
Concept ID:
CN069970
Disease or Syndrome
20.

Neonatal hemochromatosis

Neonatal hemochromatosis (NH) is characterized by hepatic failure in the newborn period and heavy iron staining in the liver. In addition, there is marked siderosis of extrahepatic tissues, including the heart and pancreas (Driscoll et al., 1988). Whitington (2007) postulated that some cases of neonatal hemochromatosis result from maternal alloimmunity directed at the fetal liver, and therefore do not represent an inherited mendelian disorder. Other causes may result from metabolic disease or perinatal infection. In particular, he commented that the disorder is not related to the family of inherited liver diseases that fall under the classification of hereditary hemochromatosis (see, e.g., 235200). Whitington (2007) proposed the term 'congenital alloimmune hepatitis.' In the past, the disorder has loosely been labeled 'neonatal hepatitis' and 'giant cell hepatitis,' which are pathologic findings in the liver representing a common response to a variety of insults, including cholestatic disorders and infection, among others (Fawaz et al., 1975; Knisely et al., 1987; Kelly et al., 2001). [from OMIM]

MedGen UID:
82768
Concept ID:
C0268059
Disease or Syndrome

Display Settings:

Format
Items per page

Send to:

Choose Destination

Supplemental Content

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...